Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations  in Australian patients with type 2 diabetes from the Fremantle Diabetes Study

In reply: We thank McCallum and colleagues for their comments. In relation to their specific points:

1 School of Medicine and Pharmacology, University of Western Australia, and Fremantle Hospital, Fremantle, WA.
2 Boden Institute of Obesity, Nutrition and Exercise, University of Sydney, Sydney, NSW.

Correspondence: wdavis@cyllene.uwa.edu.au

1. Australian Bureau of Statistics. Year book Australia, 2006. Urban and non-urban population. http://www.abs.gov.au/Ausstats/ABS@.nsf/Previousproducts/1301.0Feature%20Article72006?opendocument&tabname=Summary&prodno=1301.0 &issue=2006&num=&view= (accessed Apr 2009). (ABS Cat. No. 1301.0.)
2. Davis WA, Colagiuri S, Davis TME. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust 2009; 190: 180-184. <MJA full text>
3. Keech A, Simes RJ, Barter P, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-1861.
4. Simmons RK, Coleman RL, Price HC, et al. Performance of the UKPDS risk engine and the Framingham risk equations in estimating cardiovascular risk in the EPIC-Norfolk cohort. Diabetes Care 2009; 32: 708-713.
5. Davis WA, Knuiman MW, Davis TME. An Australian cardiovascular risk equation for type 2 diabetes: The Fremantle Diabetes Study. Int Med J 2009. Published online ahead of print: 23 Mar 2009. doi: 10.1111/j.1445-5994.2009.01958.x.

Online responses are no longer available. Please refer to our instructions for authors page for more information.